These findings provide evidence for the involvement of Aβ42 in alterations in nucleolar tau in cultured cells and in a corresponding dysfunction of protein synthesis machinery, which has been associated with mild cognitive impairment (MCI) and early stages of AD. Here, MAPT is linked to Alzheimer disease.